Last Updated:
Searching
Create account to add to watchlist!

Nova Vision Acquisition Corp - NOVV

  • Commons

    $9.92

    +0.10%

    NOVV Vol: 0.0

  • Warrants

    $0.24

    +1.39%

    NOVVW Vol: 1.1K

  • Units

    $9.85

    -1.99%

    NOVVU Vol: 130.0

Average: 0
Rating Count: 0
You Rated: Not rated

Please log in to rate.

SPAC Stats

Market Cap: 74.6M
Average Volume: 16.6K
52W Range: $9.80 - $9.98
Weekly %: +0.10%
Monthly %: -0.20%
Inst Owners: 3

Info

Target: Searching
Days Since IPO: 121
Unit composition:
Each unit has an offering price of $10.00 and consists of one ordinary share and one redeemable warrant
Trust Size: 5000000.0M

Management

Officers and Directors. Our amended and restated memorandum and articles of association provide that, subject to certain limitations, the company shall indemnify its directors and officers against all expenses, including legal fees, and against all judgments, fines and amounts paid in settlement and reasonably incurred in connection with legal, administrative or investigative proceedings. Such indemnity only applies if the person acted honestly and in good faith with a view to what the person believes is in the best interests of the company and, in the case of criminal proceedings, the person had no reasonable cause to believe that their conduct was unlawful. The decision of the directors as to whether the person acted honestly and in good faith and with a view to the best interests of the company and as to whether the person had no reasonable cause to believe that his conduct was unlawful and is, in the absence of fraud, sufficient for the purposes of the memorandum and articles of association, unless a question of law is involved. The termination of any proceedings by any judgment, order, settlement, conviction or the entering of a nolle prosequi does not, by itself, create a presumption that the person did not act honestly and in good faith and with a view to the best interests of the company or that the person had reasonable cause to believe that his conduct was unlawful. We will enter into agreements with our officers and directors to provide contractual indemnification in addition to the indemnification provided for in our amended and restated memorandum and articles of association. Our amended and restated memorandum and articles of association also will permit us to purchase and maintain insurance on behalf of any officer or director who at the request of the Company is or was serving as a director or officer of, or in any other capacity is or was acting for, another company or a partnership, joint venture, trust or other enterprise, against any liability asserted against the person and incurred by the person in that capacity, whether or not the company has or would have had the power to indemnify the person against the liability as provided in the memorandum and articles of association. We will purchase a policy of directors’ and officers’ liability insurance that insures our officers and directors against the cost of defense, settlement or payment of a judgment in some circumstances and insures us against our obligations to indemnify our officers and directors. These provisions may discourage shareholders from bringing a lawsuit against our directors for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against officers and directors, even though such an action, if successful, might otherwise benefit us and our shareholders. Furthermore, a shareholder’s investment may be adversely affected to the extent we pay the costs of settlement and damage awards against officers and directors pursuant to these indemnification provisions. We believe that these provisions, the insurance and the indemnity agreements are necessary to attract and retain talented and experienced officers and directors. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is theretofore unenforceable. PRINCIPAL SHAREHOLDERS The following table sets forth information regarding the beneficial ownership of our ordinary shares as of the date of this prospectus and as adjusted to reflect the sale of our ordinary shares included in the units offered by this prospectus (assuming none of the individuals listed purchase units in this offering), by: ● each person known by us to be the beneficial owner of more than 5% of our issued and outstanding ordinary shares; ● each of our officers and directors; and ● all of our officers and directors as a group. 90 Unless otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all ordinary shares beneficially owned by them. The following table does not reflect record of beneficial ownership of any ordinary shares issuable upon exercise of the warrants or conversion of rights as the warrants are not exercisable within 60 days of the date of this prospectus and the rights are not convertible within sixty days of the date of this prospectus. As of the date of this prospectus, there were outstanding 1,437,500 ordinary shares, including 187,500 ordinary shares subject to forfeiture if the over-allotment option is not exercised. Prior to Offering After Offering Name and Address of Beneficial Owner(1) Amount and Nature of Beneficial Ownership Approximate Percentage of Outstanding Ordinary Shares Amount and Nature of Beneficial Ownership(2) Approximate Percentage of Outstanding Ordinary Shares Nova Pulsar Holdings Limited(3) 1,097,500 76.35% 1,196,500 18.25 % Poseidon Ocean Corporation(4) 200,000 13.91% 200,000 3.05 % Eric Ping Hang Wong 100,000 6.96% 100,000 1.53 % Wing Ho Ngan(3) 1,097,500 76.35% 1,196,500 18.25 % Tin Lun Brian Cheng 10,000 *% 10,000 *% Philip Richard Herbert 10,000 *% 10,000 *% Chun Fung Horace Ma 20,000 1.39% 20,000 *% All directors and executive officers (five individuals) as a group 1,237,500 86.09% 1,336,500 20.38 % * Less than 1%. (1) Unless otherwise indicated, the business address of each of the individuals or entities is c/o Nova Vision Acquisition Corp., Room 602, 6/F, 168 Queen’s Road Central, Central, Hong Kong. (2) Assumes no exercise of the over-allotment option and includes 286,500 ordinary shares in the private placement, therefore, an aggregate of 187,500 ordinary shares held by our initial shareholders are forfeited. (3) Nova Pulsar Holdings Limited, our sponsor, is the record holder of the insider shares reported herein. Mr. Wing Ho Ngan, our Chairman, by virtue of his control over our sponsor, may be deemed to beneficially own shares held by our sponsor. (4) Poseidon Ocean Corporation, our advisor, is controlled by Mr. Kin (Stephen) Sze. Immediately after this offering, our initial shareholders will beneficially own approximately 23.43% of the then issued and outstanding ordinary shares (assuming none of them purchase any units offered by this prospectus). None of our initial shareholders, officers and directors has indicated to us that he intends to purchase securities in this offering. Because of the ownership block held by our initial shareholders, such individuals may be able to effectively exercise control over all matters requiring approval by our shareholders, including the election of directors and approval of significant corporate transactions other than approval of our initial business combination. If the underwriters do not exercise all or a portion of the over-allotment option, our initial shareholders will have up to an aggregate of 187,500 ordinary shares subject to forfeiture as required by British Virgin Islands law. Our initial shareholders will be required to have redeemed by us only a number of shares necessary to maintain their collective 20% ownership interest in our ordinary shares (excluding the private units) after giving effect to the offering and the exercise, if any, of the underwriters’ over-allotment option. All of the insider shares issued and outstanding prior to the date of this prospectus will be placed in escrow with American Stock Transfer & Trust Company, as escrow agent, until the earlier of (1) 150 calendar days after the date of the consummation of our initial business combination and the date on which the closing price of our ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after our initial business combination or (2) one year after the date of the consummation of our initial business combination, or earlier, in either case, if, subsequent to our initial business combination, we consummate a liquidation, merger, stock exchange or other similar transaction which results in all of our shareholders having the right to exchange their ordinary shares for cash, securities or other property. Up to 187,500 of the insider shares may also be released from escrow earlier than this date for forfeiture and cancellation if the over-allotment option is not exercised in full as described above. 91 During the escrow period, the holders of these shares will not be able to sell or transfer their securities except (i) to the Company’s initial shareholders, or to the Company’s officers, directors, advisors and employees, (ii) if the initial shareholder is an entity, as a distribution to partners, members or shareholders of the initial shareholder upon the liquidation and dissolution of the initial shareholder, (iii) by bona fide gift to a member of the initial shareholder’s immediate family or to a trust, the beneficiary of which is the initial shareholder or a member of the initial shareholder’s immediate family for estate planning purposes, (iv) by virtue of the laws of descent and distribution upon death of the initial shareholder, (v) pursuant to a qualified domestic relations order, (vi) by certain pledges to secure obligations incurred in connection with purchases of the Company’s securities, (vii) by private sales made in connection with the consummation of a business combination at prices no greater than the price at which the private units were originally purchased or (viii) to the Company for cancellation if the over-allotment option is not exercised or in connection with the consummation of a Business Combination, in each case, (except for clause (viii)) where the transferee agrees to the terms of the escrow agreement, but will retain all other rights as our shareholders, including, without limitation, the right to vote their ordinary shares and the right to receive cash dividends, if declared. If dividends are declared and payable in ordinary shares, such dividends will also be placed in escrow. If we are unable to effect a business combination and liquidate the trust account, none of our initial shareholders will receive any portion of the liquidation proceeds with respect to their insider shares. Our sponsor has committed to purchase from us an aggregate of 286,500 private units at $10.00 per private unit (for a total purchase price of $2,865,000). These purchases will take place on a private placement basis simultaneously with the consummation of this offering. All of the proceeds we receive from these purchases will be placed in the trust account described below. Our sponsor has also agreed that if the over-allotment option is exercised by the underwriters, they will purchase from us at a price of $10.00 per private unit an additional number of private units (up to a maximum of 21,000 private units) pro rata with the amount of the over-allotment option exercised so that at least $10.10 per share sold to the public in this offering is held in trust regardless of whether the over-allotment option is exercised in full or part. These additional private units will be purchased in a private placement that will occur simultaneously with the purchase of units resulting from the exercise of the over-allotment option. The private units are identical to the units sold in this offering except with respect to certain registration rights and transfer restrictions. Furthermore, our sponsor has agreed (A) to vote the ordinary shares underlying the private units, or “private shares,” in favor of any proposed business combination, (B) not to propose, or vote in favor of, an amendment to our amended and restated memorandum and articles of association that would stop our public shareholders from converting or selling their shares to us in connection with a business combination or affect the substance or timing of our obligation to redeem 100% of our public shares if we do not complete a business combination within 15 months (or up to 21 months if we choose to extend such period) from the closing of this offering unless we provide public shareholders with the opportunity to redeem their public shares from the trust account in connection with any such vote, (C) not to convert any private shares for cash from the trust account in connection with a shareholder vote to approve our proposed initial business combination or a vote to amend the provisions of our amended and restated memorandum and articles of association relating to shareholders’ rights or pre-business combination activity and (D) that the private shares shall not participate in any liquidating distribution upon winding up if a business combination is not consummated. The purchasers of the private units have also agreed not to transfer, assign or sell any of the private units or underlying securities (except to the same permitted transferees as the insider shares) until 30 calendar days after the completion of our initial business combination. In order to meet our working capital needs following the consummation of this offering, our initial shareholders, officers and directors or their affiliates may, but are not obligated to, loan us funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion. Each loan would be evidenced by a promissory note. The notes would either be paid upon consummation of our initial business combination, without interest, or, at the lender’s discretion, up to $500,000 of the notes may be converted upon consummation of our business combination into private units at a price of $10.00 per unit (which, for example, would result in the holders being issued units to acquire 50,000 ordinary shares and warrants to purchase 25,000 ordinary shares if $500,000 of notes were so converted). Our shareholders have approved the issuance of the units and underlying securities upon conversion of such notes, to the extent the holder wishes to so convert them at the time of the consummation of our initial business combination. If we do not complete a business combination, the loans will not be repaid. 92 The holders of our insider shares issued and outstanding on the date of this prospectus, as well as the holders of the private units (and underlying securities), and any securities issued to our initial shareholders, officers, directors or their affiliates in payment of working capital loans made to us, will be entitled to registration rights pursuant to an agreement to be signed prior to or on the effective date of this offering. The holders of a majority of these securities are entitled to make up to two demands that we register such securities. The holders of the majority of the insider shares can elect to exercise these registration rights at any time commencing three months prior to the date on which these ordinary shares are to be released from escrow. The holders of the private units (and underlying securities) and the securities issued in payment of working capital loans (or underlying securities) can elect to exercise these registration rights at any time after we consummate a business combination. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to our consummation of a business combination. We will bear the expenses incurred in connection with the filing of any such registration statements. Our sponsor and our executive officers and directors are deemed to be our “promoters,” as that term is defined under the Federal securities laws. CERTAIN TRANSACTIONS In March 2021, 1,150,000 insider shares were issued to our sponsor for an aggregate purchase price of $25,000, and 100,000 insider shares were issued to Poseidon Ocean Corporation, our advisor, as consideration for its agreeing to be advisor to our board of directors. In April 2021, the Sponsor transferred 240,000 insider shares to our officers, directors and advisor and the Company further allotted an aggregate of 187,500 insider shares to our sponsor, resulting in an aggregate of 1,437,500 ordinary shares outstanding to our initial shareholders. If the underwriters do not exercise all or a portion of their over-allotment option, our initial shareholders have agreed that up to an aggregate of 187,500 ordinary shares in proportion to the portion of the over-allotment option that was not exercised are subject to forfeiture and would be immediately cancelled. If the underwriters determine the size of the offering should be increased (including pursuant to Rule 462(b) under the Securities Act) or decreased, a share capitalization or a contribution back to capital, as applicable, would be effectuated in order to maintain our initial shareholder’s ownership at a percentage of the number of shares to be sold in this offering. Our sponsor has committed to purchase from us an aggregate of 286,500 private units at $10.00 per private unit (for a total purchase price of $2,865,000). These purchases will take place on a private placement basis simultaneously with the consummation of this offering. All of the proceeds we receive from these purchases will be placed in the trust account described below. Our sponsor has also agreed that if the over-allotment option is exercised by the underwriters, they will purchase from us at a price of $10.00 per private unit an additional number of private units (up to a maximum of 21,000 private units) pro rata with the amount of the over-allotment option exercised so that at least $10.10 per share sold to the public in this offering is held in trust regardless of whether the over-allotment option is exercised in full or part. These additional private units will be purchased in a private placement that will occur simultaneously with the purchase of units resulting from the exercise of the over-allotment option. The private units are identical to the units sold in this offering except as otherwise described in this prospectus. The purchasers have agreed not to transfer, assign or sell any of the private units or the underlying securities (except to the same permitted transferees as the insider shares) until 30 calendar days after the completion of our initial business combination. In order to meet our working capital needs following the consummation of this offering, our initial shareholders, officers and directors and their respective affiliates may, but are not obligated to, loan us funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion. Each loan would be evidenced by a promissory note. The notes would either be paid upon consummation of our initial business combination, without interest, or, at the lender’s discretion, up to $500,000 of the notes may be converted upon consummation of our business combination into private units at a price of $10.00 per unit (which, for example, would result in the holders being issued units to acquire 50,000 ordinary shares and warrants to purchase 25,000 ordinary shares if $500,000 of notes were so converted). Our shareholders have approved the issuance of the units and underlying securities upon conversion of such notes, to the extent the holder wishes to so convert them at the time of the consummation of our initial business combination. If we do not complete a business combination, the loans would be repaid out of funds not held in the trust account, and only to the extent available. 9

Holder Stats

1 0
% of Shares Held by All Insider 20.44%
% of Shares Held by Institutions 15.76%
% of Float Held by Institutions 19.81%
Number of Institutions Holding Shares 3

Institutional Holders

Reporting Date Hedge Fund Shares Held Market Value % of Portfolio Quarterly Change in Shares Ownership in Company
2021-11-12 Weiss Asset Management LP 480,000 $4,800,000 0.1% 0 6.385%
2021-11-12 K2 Principal Fund L.P. 270,000 $2,650,000 0.2% 0 3.591%

SEC Filings

Form Type Form Description Filing Date Document Link
10-Q 2021-11-12 https://www.sec.gov/Archives/edgar/data/1858028/000149315221028016/form10-q.htm
10-Q 2021-09-14 https://www.sec.gov/Archives/edgar/data/1858028/000149315221022638/form10-q.htm
SC 13G SC 13G 2021-08-16 https://www.sec.gov/Archives/edgar/data/1858028/000110465921106396/tm2125232d1_sc13g.htm
SC 13G FORM SC 13G 2021-08-16 https://www.sec.gov/Archives/edgar/data/1858028/000106299321007552/formsc13g.htm
8-K/A 2021-08-16 https://www.sec.gov/Archives/edgar/data/1858028/000149315221019999/form8-ka.htm
8-K 2021-08-10 https://www.sec.gov/Archives/edgar/data/1858028/000149315221019218/form8-k.htm
3 2021-08-10 https://www.sec.gov/Archives/edgar/data/1858028/000149315221019143/xslF345X02/ownership.xml
3 2021-08-10 https://www.sec.gov/Archives/edgar/data/1858028/000149315221019142/xslF345X02/ownership.xml
3 2021-08-10 https://www.sec.gov/Archives/edgar/data/1858028/000149315221019141/xslF345X02/ownership.xml
3 2021-08-10 https://www.sec.gov/Archives/edgar/data/1858028/000149315221019140/xslF345X02/ownership.xml
3 2021-08-10 https://www.sec.gov/Archives/edgar/data/1858028/000149315221019139/xslF345X02/ownership.xml
3 2021-08-10 https://www.sec.gov/Archives/edgar/data/1858028/000149315221019138/xslF345X02/ownership.xml
424B4 2021-08-06 https://www.sec.gov/Archives/edgar/data/1858028/000149315221018878/form424b4.htm
EFFECT 2021-08-05 https://www.sec.gov/Archives/edgar/data/1858028/999999999521003059/xslEFFECTX01/primary_doc.xml
CERT 2021-08-05 https://www.sec.gov/Archives/edgar/data/1858028/000135445721000903/8A_cert_NOVV.pdf
8-A12B 2021-08-05 https://www.sec.gov/Archives/edgar/data/1858028/000149315221018651/form8a-12b.htm
CORRESP 2021-08-04 https://www.sec.gov/Archives/edgar/data/1858028/000149315221018507/filename1.htm
CORRESP 2021-08-04 https://www.sec.gov/Archives/edgar/data/1858028/000149315221018506/filename1.htm
S-1/A 2021-07-30 https://www.sec.gov/Archives/edgar/data/1858028/000149315221018176/forms-1a.htm
CORRESP 2021-07-20 https://www.sec.gov/Archives/edgar/data/1858028/000149315221017361/filename1.htm
S-1/A 2021-07-20 https://www.sec.gov/Archives/edgar/data/1858028/000149315221017360/forms-1a.htm
UPLOAD 2021-07-15 https://www.sec.gov/Archives/edgar/data/1858028/000000000021008760/filename1.pdf
CORRESP 2021-07-02 https://www.sec.gov/Archives/edgar/data/1858028/000149315221016008/filename1.htm
S-1/A 2021-07-02 https://www.sec.gov/Archives/edgar/data/1858028/000149315221016006/forms-1a.htm
UPLOAD 2021-06-25 https://www.sec.gov/Archives/edgar/data/1858028/000000000021007863/filename1.pdf
S-1 2021-06-15 https://www.sec.gov/Archives/edgar/data/1858028/000149315221014450/forms-1.htm
CORRESP 2021-06-15 https://www.sec.gov/Archives/edgar/data/1858028/000149315221014449/filename1.htm
UPLOAD 2021-05-26 https://www.sec.gov/Archives/edgar/data/1858028/000000000021006614/filename1.pdf
DRS 2021-04-29 https://www.sec.gov/Archives/edgar/data/1858028/000149315221009976/filename1.htm